Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Gross Margin (2016 - 2025)

Rockwell Medical's Gross Margin history spans 16 years, with the latest figure at 21.14% for Q4 2025.

  • For Q4 2025, Gross Margin rose 642.0% year-over-year to 21.14%; the TTM value through Dec 2025 reached 16.89%, down 34.0%, while the annual FY2025 figure was 16.89%, 34.0% down from the prior year.
  • Gross Margin reached 21.14% in Q4 2025 per RMTI's latest filing, up from 14.27% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 22.03% in Q3 2024 to a low of 14.55% in Q4 2021.
  • Average Gross Margin over 5 years is 9.06%, with a median of 12.55% recorded in 2022.
  • Peak YoY movement for Gross Margin: plummeted -1709bps in 2021, then surged 2667bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 14.55% in 2021, then soared by 183bps to 12.12% in 2022, then rose by 7bps to 12.99% in 2023, then grew by 13bps to 14.72% in 2024, then soared by 44bps to 21.14% in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Gross Margin are 21.14% (Q4 2025), 14.27% (Q3 2025), and 15.57% (Q2 2025).